课题基金 / 基金详情

Mechanism s regulating the gene rearrangements in immune system

Mechanism s regulating the gene rearrangements in immune system
免疫系统基因重排的调节机制
批准号:
18390084
负责人:
SHIMIZU Akira
金额:
$9.84万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

SHIMIZU Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The most unque character in acquired immunity is that genes encoding receptors for antigen undergo rearrangements by DNA recombination to acquire and expand their function in the immune-competent lymphocytes. Furthermore these rearrangements determine the differentiation stage of the lymphocyte. The antigen receptor genes are completed by the rearrangements of variable regions, and this enables the receptors to bind specifically to the antigen. by this, each individual lymphocyte can recognize a specific antigen and thus immune system as whole can recognize a wide variety of antigens. In addition, antibodies act as effecter to eliminate or neutralize antigens. To expand such effecter function of antibody according to the route through which the antigens invade, the constant region genes of its heavy chain also rearrange during activation of B lymphocyte (class switch recombination, CSR).In this study, we tried to elucidate the molecular mechanisms controlling the rearrangements per se and target gene specificity by analyzing transcription factors involved in the rearrangement process. We found that the transcription factors, Pax5, E2A, SIP, NF_KB, IRF4, and Runx1-3 are involved and important in the specific regulation of target gene selection and expression of AID gene that is essential for CSR. These factors together with Id2 form epigenetic regulatory circuits downstream to TFG-β signal. We also found that expression of these factors is affected by the micro-environment formed by a dynamic reorganization and neogenesis of the secondary and tertiary lymphoid tissues, and in some case these factors showed a redundant function but in other case they Showed opposite function. Such mechanism increases the complexity of the regulation.In addition, using a combination of stimuli we established an efficient method to induce CSR specifically to IgA in vitro that has been very difficult up to now.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IL-21 induces inhibitor of differentiation 2(Id2)and leads to complete abrogation of anapbylaxis in mice.
IL-21 诱导分化抑制剂 2 (Id2) 并导致小鼠的过敏反应完全消除。
DOI: --
发表时间: 2006
期刊: J. Immunol. 117・11
影响因子: --
作者: [Kishida, T., et. al.]
通讯作者: et. al.
DOI: 10.1677/joe.1.06442
发表时间: 2006-02-01
期刊: JOURNAL OF ENDOCRINOLOGY
影响因子: 4
作者: [Akamizu, T, Murayama, T, Kangawa', K]
通讯作者: Kangawa', K
IL-21 induces inhibitor of differentiation 2 (Id2) and leads to complete abrogation of anaphylaxis in mice.
IL-21 诱导分化抑制剂 2 (Id2) 并导致小鼠过敏反应完全消除。
DOI: --
发表时间: 2007
期刊: J Immunol 179
影响因子: --
作者: [Kishida T, Hiromura Y, Shin-Ya M, Asada H, Kuriyama H, Sugai M, Shimizu A, Yokota Y, Hama T, Imanishi J, Hisa Y, Mazda O.]
通讯作者: Mazda O.
A transmwmbrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesion
由淋巴结成纤维细胞网状细胞表达的跨膜趋化因子 CXC 趋化因子配体 16 具有调节 T 细胞迁移和粘附的潜力
DOI: --
发表时间: 2006
期刊: Intemat. Immunol 18
影响因子: --
作者: [Hara, T., Katakai, T., Lee, J.-H., Nambu, Y., Nakajima-Nagata, N., Gonda, H., Sugai, M., Shimizu, A]
通讯作者: A
11
    Elevated type I interferon expression in dermatomyositis: involvement of LINE-1 and viral infection.
    Statistical mechanics based on pure quantum states
    • 批准号:
      26287085
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.32万
    • 财政年份:
      2014
    • 负责人:
      SHIMIZU Akira
    • 依托单位:
    A Study on Developing English, Chinese and Malay Teaching Materials Based on Communicating in Laboratories of Electronics
    • 批准号:
      26370690
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.58万
    • 财政年份:
      2014
    • 负责人:
      SHIMIZU Akira
    • 依托单位:
    Immunological network in ANCA associated glomerulonephritis
    • 批准号:
      24591217
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      SHIMIZU Akira
    • 依托单位:
    海外基金